UK Doctors Develop Non-Invasive Test for Womb Cancer Diagnosis

1-Minute Brief

The new test may reduce the need for invasive procedures in women with postmenopausal bleeding.

Key Facts

• Doctors have developed a test using urine and vaginal fluid samples to help rule out womb cancer.
• The test is intended for women who experience bleeding after menopause.
• The approach could spare thousands of lower-risk women from internal ultrasounds and hysteroscopies.
• Around 10,200 women are diagnosed with womb cancer in the UK every year.
• The new method is described as simple and non-invasive.

What Happened

UK doctors have created a non-invasive test using urine and vaginal fluid samples to help rule out womb cancer in women with postmenopausal bleeding.

Why It Matters

This development may improve patient comfort and reduce healthcare costs by decreasing the number of invasive diagnostic procedures required for suspected womb cancer.

What's Next

Further studies and potential implementation in clinical practice may follow to assess the test's effectiveness and impact on current diagnostic pathways.